PAVmed Inc. PAVM
3.85
(0.03)
(0.77%)
as of 25 Sep
- Market cap
- $31.0M
- P/E
- 0.0×
Follow PAVM
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
8.40% | 59.31% | (167.96%) | (216.61%) | |
| (1.73%) | (10.86%) | (57.93%) | (49.05%) | ||
ROIC |
(64.98%) | (65.64%) | (45.61%) | (54.50%) | |
Return on Tangible Assets |
9.62% | 30.93% | (743.20%) | (2,446.98%) | |
Average Days of Receivables |
37.76 | 77.11 | 90.18 | 52.14 | |
Free Cash Flow per Share |
(4.99) | (7.81) | (3.98) | (1.24) | |
Free Cash Flow |
(3.58) | (5.24) | (6.29) | (7.78) | |
Capital Expenditures |
(0.02) | (0.03) | (0.05) | (0.05) | |
Piotroski F-Score |
1.00 | 1.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(13.89%) | (21.84%) | (13.47%) | (20.24%) | |
Accounts Receivable Turnover |
3.05 | 4.30 | 5.67 | 11.79 | |
Accounts Payable Turnover |
0.45 | 0.33 | 0.41 | 0.50 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
689.67 | 1,135.18 | 1,286.00 | 1,070.67 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
11,975.86% | 6,326.76% | 5,991.76% | 5,687.50% | |
Selling, General and Administrative Expense of Revenue |
57,134.48% | 24,178.87% | 22,480.00% | 17,932.14% | |
Share Based Compensation of Revenue |
7,613.79% | 2,404.23% | 1,128.24% | 1,530.36% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
5.98 | 1.38 | 0.22 | 0.37 | |
Depreciation/Fixed assets |
1.93 | 1.36 | 1.04 | 1.08 | |
Capex/Depreciation |
(0.13) | (0.30) | (0.57) | (0.66) | |
Revenue per Share |
0.04 | 0.11 | 0.05 | 0.02 | |
Operating CF per Share |
(4.96) | (7.76) | (3.95) | (1.23) | |
Capex per Share |
(0.03) | (0.05) | (0.03) | (0.01) | |
Capex to Sales |
0.72 | 0.44 | 0.55 | 0.46 | |
Net Profit Margin |
(2,051.72%) | (5,315.49%) | (33,478.82%) | (18,417.86%) |
Columns are period end dates